Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -14.33% is 44% above its 5-year average of -25.57%, around the middle of its 5-year range (-61.70%–17.42%).
78.09% below its 12-month average of -8.05%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -12.95%.
OPERATING MARGIN
-14.33%
OPERATING MARGIN AVG TTM
-8.05%
OPERATING MARGIN AVG 3Y
-25.88%
OPERATING MARGIN AVG 5Y
-25.57%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-78.09%
CURRENT VS 3Y AVG
+44.62%
CURRENT VS 5Y AVG
+43.97%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
10x Genomics, Inc.
Market Cap
$10.19B
Operating Margin
-14.33%
TTM Avg
-8.05%
3Y Avg
-25.88%
5Y Avg
-25.57%
Market Cap
$10.33B
Operating Margin
20.75%
TTM Avg
11.46%
3Y Avg
13.43%
5Y Avg
14.29%
Market Cap
$10.30B
Operating Margin
-226.00%
TTM Avg
-1280.12%
3Y Avg
-51793.49%
5Y Avg
-46507.49%
Market Cap
$10.21B
Operating Margin
0.66%
TTM Avg
2.96%
3Y Avg
3.72%
5Y Avg
4.01%
Market Cap
$10.20B
Operating Margin
13.33%
TTM Avg
15.23%
3Y Avg
16.08%
5Y Avg
17.45%
Market Cap
$10.55B
Operating Margin
-31.91%
TTM Avg
-53.37%
3Y Avg
-77.67%
5Y Avg
-96.92%
Market Cap
$10.03B
Operating Margin
8.52%
TTM Avg
8.41%
3Y Avg
8.37%
5Y Avg
8.78%
Market Cap
$9.97B
Operating Margin
8.32%
TTM Avg
1.27%
3Y Avg
9.53%
5Y Avg
14.21%
Market Cap
$9.96B
Operating Margin
9.08%
TTM Avg
10.48%
3Y Avg
12.70%
5Y Avg
14.08%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 10x Genomics, Inc. (TXG) | $10.19B | -14.33% | -8.05% | -25.88% | -25.57% |
| Globus Medical, Inc. (GMED)vs › | $10.33B | 20.75% | 11.46% | 13.43% | 14.29% |
| ImmunityBio, Inc. (IBRX)vs › | $10.30B | -226.00% | -1280.12% | -51793.49% | -46507.49% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 0.66% | 2.96% | 3.72% | 4.01% |
| Align Technology, Inc. (ALGN)vs › | $10.20B | 13.33% | 15.23% | 16.08% | 17.45% |
| Twist Bioscience Corporation (TWST)vs › | $10.55B | -31.91% | -53.37% | -77.67% | -96.92% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 8.52% | 8.41% | 8.37% | 8.78% |
| Repligen Corporation (RGEN)vs › | $9.97B | 8.32% | 1.27% | 9.53% | 14.21% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.96B | 9.08% | 10.48% | 12.70% | 14.08% |
| Universal Health Services, Inc. (UHS)vs › | $10.75B | 11.36% | 11.05% | 9.46% | 10.06% |
Gross Margin
70.0%
Operating Margin
-14.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -12.95% |
| 2026-03-31 | -11.30% |
| 2025-12-31 | -11.77% |
| 2025-09-30 | -21.64% |
| 2025-06-30 | 17.42% |
| 2025-03-31 | -25.39% |
| 2024-12-31 | -30.20% |
| 2024-09-30 | -27.36% |
| 2024-06-30 | -27.26% |
| 2024-03-31 | -43.61% |
| 2023-12-31 | -30.00% |
| 2023-09-30 | -61.70% |
| 2023-06-30 | -43.15% |
| 2023-03-31 | -38.71% |
| 2022-12-31 | -14.78% |
| 2022-09-30 | -30.51% |
| 2022-06-30 | -55.07% |
| 2022-03-31 | -36.45% |
| 2021-12-31 | -11.03% |
| 2021-09-30 | -12.67% |
| 2021-06-30 | -8.92% |
| 2021-03-31 | -9.65% |
| 2020-12-31 | -364.99% |
| 2020-09-30 | -90.86% |
| 2020-06-30 | -91.88% |
| 2020-03-31 | -27.65% |
| 2019-12-31 | -10.73% |
| 2019-09-30 | -14.86% |
| 2019-06-30 | -18.56% |
| 2019-03-31 | -5.66% |
| 2018-12-31 | -148.29% |
| 2018-09-30 | -40.79% |
| 2018-06-30 | -17.17% |
| 2018-03-31 | -24.78% |
